Navigation Links
Skinvisible Signs Dermatology Agreement With RHEI Pharmaceuticals
Date:2/4/2009

skin care products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare patent. Skinvisible's value also lies in its ability to continually generate new IP on dermatology and medical products formulated with Invisicare. www.skinvisible.com

About RHEI Pharmaceuticals

RHEI Pharmaceuticals (RHEI) is a specialty pharmaceutical company focused on bringing core medicines from the U.S., Europe and Japan, into the fast-growing Chinese marketplace. RHEI in-licenses approved and late stage pharmaceutical products from these reference countries, and applies its development and regulatory expertise to bring these important therapies to China. RHEI's internal capabilities encompass business development, regulatory approval and clinical development - combining a western approach to pharmaceuticals with Chinese professionals that are highly experienced in the region. www.rheipharma.com

Forward-Looking Statements: This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10Q for the quarter ending September 30, 2008).

    Corporate Contact:
    Doreen McMorran
    Skinvisible Pharmaceuticals, Inc.
    Phone: 702
'/>"/>
SOURCE  Skinvisible, Inc.; RHEI Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 

Related medicine news :

1. Skinvisible and Cambrex Enter Into Agreement to Develop Acne Products
2. Skinvisible Appoints Dr. Geert Cauwenbergh to Its International Advisory Board
3. Skinvisible Offers 8 Hour Photostablity for Parsol 1789
4. Skinvisible Appoints New Vice President of Business Development & Marketing
5. Skinvisible Signs Licensing Agreement for Two Acne Formulations
6. Skinvisible Appoints New Board Member
7. Skinvisible Announces Licensing Agreement for Adapalene
8. Skinvisible Signs Marketing Agreement for India
9. Skinvisible Appoints Dr. George Korkos to Its Advisory Board
10. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
11. CSC Signs Five-Year Outsourcing Extension With Aspen Valley Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Primary Children’s Hospital from nearby hot tub company helps raise ... , ... Salt Lake City, UT (PRWEB) ... announce the donation of a Bullfrog Spa to aid in ... Lake City, Utah. Primary Children’s Medical Center, serving child patients ...
(Date:12/16/2009)... N.J., Dec. 16 Smart Balance, Inc. (Nasdaq: ... directors has authorized a two-year stock repurchase program of ... "The repurchase program demonstrates the confidence we have in ... to deliver long-term value for all of our shareholders, ... funds," said Stephen Hughes, Smart Balance, Inc. Chairman and ...
(Date:12/16/2009)... gain full benefit from breakthroughs, experts say, , , WEDNESDAY, ... lines currently used for research come mostly from white ... mean that non-whites will benefit less from any medical ... experts say. , Blacks could be especially affected. In ... lines studied showed any traces of recent African ancestry, ...
(Date:12/16/2009)... For wounded U.S. servicemen and women recovering ... the holidays can be a particularly difficult time. ... more than ever on the healing power of connecting ... just got easier for Walter Reed patients as Verizon ... provide hundreds of minutes of holiday talk time for ...
(Date:12/16/2009)... second, possibly deadly, attack is long-term goal, researchers say ... have developed a tool to predict whether a patient ... a first stroke. , "This is an important new ... a second stroke soon after a first stroke are ... Hakan Ay, of Massachusetts General Hospital and Harvard Medical ...
Breaking Medicine News(10 mins):Health News:Bullfrog Spas Helps Critically Ill Children 2Health News:Bullfrog Spas Helps Critically Ill Children 3Health News:Bullfrog Spas Helps Critically Ill Children 4Health News:Smart Balance Authorizes Stock Repurchase Program 2Health News:Most Stem Cells Used in Research Come From Whites 2Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:New Stroke Tool May Predict Early Recurrence 2
... AIDS patients appear to play a role in containing and slowing ... ,The researchers hope their finding will lead to a vaccine that ... genes, and help the body's own immune system overcome an infection. ... in a study to appear in the Friday edition of the ...
... American socialite Ivana Trump has confirmed that she is set ... ,However, the confirmation will come as a ... recently. ,The ex-wife of Donald Trump revealed her ... magazine for which she writes a weekly advice column. ...
... voted to hike the taxes on tobacco in order to ... move came in the face of a threat from the President ... the panel , join all 11 Democrats in supporting the plan. ... has been a federal-state collaboration with broad support from both parties. ...
... interview clip in which pop star Lily Allen showed off her ... You Tube. ,The 90-second clip has been viewed ... it the fourth most viewed video. ,The Smile singer, ... point when Friends character Chandler Bing spoke about 'nubbin'. ...
... trying their bit to solve the problem of carbon emission. They ... fumes into biofuel. ,The box can be ... traps the unwanted gases. These unwanted gases are also called green ... add to the global warming. The box then emits water vapor. ...
... radiation exposure from a computed tomography (CT scan) coronary ... and younger patients, according to an analysis based ... in the journal JAMA, was conducted by a team ... Columbia University College of Physicians and Surgeons, New York. ...
Other Medicine News:Health News:Three Gene Variants Could Hold Key for HIV Vaccine: Study 2Health News:U.S President Defied-Senate Votes To Expand Child Health Insurance 2Health News:Green Box Converts Car Fumes into Biofuel 2Health News:Women, Younger Patients at Greater Lifetime Cancer Risk from CT Scan 2
(Date:12/16/2009)... group of national medical societies launched a multi-state advertising ... and Affordable Care Act, currently under consideration by the ... vote in the coming days. The groups are ... health care bill that is "bad medicine" for patients. ... care system needs reform - but the current Senate ...
(Date:12/16/2009)... WORTH, Texas, Dec. 16 Wound ... a rapidly growing provider of specialty medical ... operating subsidiary is moving toward productization of ... The company currently anticipates products to be ... market, estimated to be a multi-billion dollar ...
(Date:12/16/2009)... HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) an online U.S. ... in 12% per annum short term debt financing. ... drawdown of $500,000, with accrued interest and principal repayable ... accrued interest and principal repayable in one year from ... positive for any calendar month prior to December 15, ...
Breaking Medicine Technology:Physician Groups Oppose Current Senate Health Care Reform Bill 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System 47463 1Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System 47463 2Endologix Announces Full Commercial Launch of IntuiTrak Express Delivery System 47463 3BayCare Named CIO 100 Award Winner by CIO Magazine 47458 1BayCare Named CIO 100 Award Winner by CIO Magazine 47458 2BayCare Named CIO 100 Award Winner by CIO Magazine 47458 3BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research 47453 1BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research 47453 2
... the Treatment,s ,Low Rates of Morbidity, IRVINE, ... ), an innovative medical device company focused on ... and,interventional radiologists for tissue and tumor ablation, announced ... morbidity" in the,July issue of Urology Times. Focal ...
... Mean the End of Anti-Amyloid,Therapies -, CHICAGO, ... new treatments for Alzheimer,s - even an unsuccessful ... and point scientists,toward advances in therapies for the ... Alzheimer,s Association International Conference,on Alzheimer,s Disease (ICAD 2008), ...
Other Medicine Technology:Focal Cryoablation Highlighted in Urology Times Best of AUA Orlando 2008 2Focal Cryoablation Highlighted in Urology Times Best of AUA Orlando 2008 3Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 2Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 3Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 4Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 5Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 6Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 7Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 8Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 9Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 10Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation 11
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
... most complex grinding formula to ... lens, are specifically manufactured to ... precision as the lenses used ... refractor. Marco custom trial lens ...
Non-Illuminated Trial Lens Set is an attractive set of trial lenses worked to a high standard of accuracy....
This is a reduced form of the 100 Hue test and is obviously quicker to administer. It provides extensive chromatic sensitivity and gives a quantitative score. Kit includes 100 score pads....
Medicine Products: